Bio-Techne
614 McKinley Place N.E.
Minneapolis
Minnesota
55413
United States
Website: http://www.bio-techne.com/
405 articles about Bio-Techne
-
Bio-Techne to Host Conference Call on May 1, 2024, to Announce Third Quarter Fiscal 2024 Financial Results
4/10/2024
Bio-Techne Corporation announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at 8:00 a.m. CDT to review third quarter fiscal 2024 financial results.
-
Bio-Techne Surpasses 10,000 Peer-Reviewed Publications Citing RNAscope Technology
4/8/2024
Bio-Techne Corporation announced that Advanced Cell Diagnostics, part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and application of RNAscope™ ISH technology.
-
Bio-Techne to Present at the 2024 American Association for Cancer Research (AACR) Conference
4/3/2024
Bio-Techne Corporation announced it will showcase its portfolio of solutions to advance cancer research from target discovery to cell therapy development at the upcoming annual meeting of the American Association for Cancer Research, taking place April 5-10, 2024, in San Diego, California.
-
Bio-Techne Receives CiteAb'S ELISA Kit Supplier of the Year and Spatial Biology Innovation Awards
4/1/2024
Bio-Techne Corporation announced that its R&D Systems brand has been named "ELISA Kit Supplier of the Year" in CiteAb's prestigious annual industry awards.
-
Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
3/28/2024
Nikon Instruments Inc. is pleased to announce that they have entered into a partnership with Lunaphore, part of Bio-Techne Corporation's Spatial Biology Division, to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.
-
Bio-Techne and Nikon Instruments Inc. Announce Partnership to Expand Access to Innovative Spatial Biology Services
3/28/2024
Bio-Techne Corporation is pleased to announce that Lunaphore, part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.
-
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
3/22/2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, part of Bio-Techne's Molecular Diagnostics Division, has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation.
-
Bio-Techne to Present at the Barclays 26th Annual Global Healthcare Conference
3/6/2024
Bio-Techne Corporation announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024, at 8:30 a.m. EDT.
-
BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
2/1/2024
Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023.
-
BIO-TECHNE DECLARES DIVIDEND - February 1, 2024
2/1/2024
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2023.
-
Lunaphore and ACD Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application
1/25/2024
Bio-Techne Corporation announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics, will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.
-
BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS
1/16/2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, February 1, 2024 , at 8:00 a.m. CST to review second quarter fiscal 2024 financial results.
-
Bio-Techne Announces Appointment of Matthew F. McManus as President, Diagnostics and Genomics Segment
1/5/2024
Bio-Techne Corporation announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024.
-
BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
1/4/2024
Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and manufacturing at Phacilitate's Advanced Therapies Week , taking place January 16-19 at the Miami Beach Convention Center in Miami, Florida.
-
BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
12/21/2023
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, current Chief Operating Officer, and Chief Executive Officer effective February 1, 2024, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:00 a.m. PST.
-
Lunaphore and SIB Awarded Innosuisse Funding to Develop Innovative AI-based Assay Development Tools
12/14/2023
Bio-Techne Corporation announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding for an innovation project.
-
BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
11/27/2023
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth , President and Chief Executive Officer, and Kim Kelderman , Chief Operating Officer will present at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023, at 2:10 p.m. EST.
-
Bio-Techne to Present at Investor Healthcare Conferences - November 13, 2023
11/13/2023
Bio-Techne Corporation announced that it will present at the following investor conferences.
-
Asuragen to Present Novel Clinical Testing Data at AMP 2023 Conference
11/2/2023
Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, will present new data on clinical laboratory testing solutions related to cystic fibrosis variant detection, cancer monitoring, resolving conventionally inaccessible, disease-causing genes, and more at the upcoming meeting of the Association for Molecular Pathology, to be held November 14-18 in Salt Lake City, Utah.
-
Bio-Techne Releases First Quarter Fiscal 2024 Results
10/31/2023
Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2023.